Global Persistent Facial Erythema Treatment Market Research Report 2023

Facial erythema is a very common reason for consulting a dermatologist.

The global Persistent Facial Erythema Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

While often a manifestation of a benign condition, in some cases facial erythema may be the first sign of a more serious disorder and specific diagnostic tests are needed to rule out these diseases.

This report aims to provide a comprehensive presentation of the global market for Persistent Facial Erythema Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Persistent Facial Erythema Treatment.

The Persistent Facial Erythema Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Persistent Facial Erythema Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Persistent Facial Erythema Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Persistent Facial Erythema Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Emollients

1.2.3 Antihistamines

1.2.4 Antifungal

1.2.5 Antibiotics

1.2.6 Corticosteroids

1.2.7 Calcineurin Inhibitors

1.3 Market by Application

1.3.1 Global Persistent Facial Erythema Treatment Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospitals

1.3.3 Ambulatory Surgical Centers

1.3.4 Clinics

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Persistent Facial Erythema Treatment Market Perspective (2018-2029)

2.2 Persistent Facial Erythema Treatment Growth Trends by Region

2.2.1 Global Persistent Facial Erythema Treatment Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Persistent Facial Erythema Treatment Historic Market Size by Region (2018-2023)

2.2.3 Persistent Facial Erythema Treatment Forecasted Market Size by Region (2024-2029)

2.3 Persistent Facial Erythema Treatment Market Dynamics

2.3.1 Persistent Facial Erythema Treatment Industry Trends

2.3.2 Persistent Facial Erythema Treatment Market Drivers

2.3.3 Persistent Facial Erythema Treatment Market Challenges

2.3.4 Persistent Facial Erythema Treatment Market Restraints

3.1 Global Top Persistent Facial Erythema Treatment Players by Revenue

3.1.1 Global Top Persistent Facial Erythema Treatment Players by Revenue (2018-2023)

3.1.2 Global Persistent Facial Erythema Treatment Revenue Market Share by Players (2018-2023)

3.2 Global Persistent Facial Erythema Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Persistent Facial Erythema Treatment Revenue

3.4 Global Persistent Facial Erythema Treatment Market Concentration Ratio

3.4.1 Global Persistent Facial Erythema Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Persistent Facial Erythema Treatment Revenue in 2022

3.5 Persistent Facial Erythema Treatment Key Players Head office and Area Served

3.6 Key Players Persistent Facial Erythema Treatment Product Solution and Service

3.7 Date of Enter into Persistent Facial Erythema Treatment Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Persistent Facial Erythema Treatment Historic Market Size by Type (2018-2023)

4.2 Global Persistent Facial Erythema Treatment Forecasted Market Size by Type (2024-2029)

5.1 Global Persistent Facial Erythema Treatment Historic Market Size by Application (2018-2023)

5.2 Global Persistent Facial Erythema Treatment Forecasted Market Size by Application (2024-2029)

6.1 North America Persistent Facial Erythema Treatment Market Size (2018-2029)

6.2 North America Persistent Facial Erythema Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Persistent Facial Erythema Treatment Market Size by Country (2018-2023)

6.4 North America Persistent Facial Erythema Treatment Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Persistent Facial Erythema Treatment Market Size (2018-2029)

7.2 Europe Persistent Facial Erythema Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Persistent Facial Erythema Treatment Market Size by Country (2018-2023)

7.4 Europe Persistent Facial Erythema Treatment Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Persistent Facial Erythema Treatment Market Size (2018-2029)

8.2 Asia-Pacific Persistent Facial Erythema Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Persistent Facial Erythema Treatment Market Size by Region (2018-2023)

8.4 Asia-Pacific Persistent Facial Erythema Treatment Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Persistent Facial Erythema Treatment Market Size (2018-2029)

9.2 Latin America Persistent Facial Erythema Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Persistent Facial Erythema Treatment Market Size by Country (2018-2023)

9.4 Latin America Persistent Facial Erythema Treatment Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Persistent Facial Erythema Treatment Market Size (2018-2029)

10.2 Middle East & Africa Persistent Facial Erythema Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Persistent Facial Erythema Treatment Market Size by Country (2018-2023)

10.4 Middle East & Africa Persistent Facial Erythema Treatment Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Anacor Pharmaceuticals

11.1.1 Anacor Pharmaceuticals Company Detail

11.1.2 Anacor Pharmaceuticals Business Overview

11.1.3 Anacor Pharmaceuticals Persistent Facial Erythema Treatment Introduction

11.1.4 Anacor Pharmaceuticals Revenue in Persistent Facial Erythema Treatment Business (2018-2023)

11.1.5 Anacor Pharmaceuticals Recent Development

11.2 Astellas Pharma

11.2.1 Astellas Pharma Company Detail

11.2.2 Astellas Pharma Business Overview

11.2.3 Astellas Pharma Persistent Facial Erythema Treatment Introduction

11.2.4 Astellas Pharma Revenue in Persistent Facial Erythema Treatment Business (2018-2023)

11.2.5 Astellas Pharma Recent Development

11.3 Galderma

11.3.1 Galderma Company Detail

11.3.2 Galderma Business Overview

11.3.3 Galderma Persistent Facial Erythema Treatment Introduction

11.3.4 Galderma Revenue in Persistent Facial Erythema Treatment Business (2018-2023)

11.3.5 Galderma Recent Development

11.4 Meda Pharmaceuticals

11.4.1 Meda Pharmaceuticals Company Detail

11.4.2 Meda Pharmaceuticals Business Overview

11.4.3 Meda Pharmaceuticals Persistent Facial Erythema Treatment Introduction

11.4.4 Meda Pharmaceuticals Revenue in Persistent Facial Erythema Treatment Business (2018-2023)

11.4.5 Meda Pharmaceuticals Recent Development

11.5 Novartis

11.5.1 Novartis Company Detail

11.5.2 Novartis Business Overview

11.5.3 Novartis Persistent Facial Erythema Treatment Introduction

11.5.4 Novartis Revenue in Persistent Facial Erythema Treatment Business (2018-2023)

11.5.5 Novartis Recent Development

11.6 Pfizer

11.6.1 Pfizer Company Detail

11.6.2 Pfizer Business Overview

11.6.3 Pfizer Persistent Facial Erythema Treatment Introduction

11.6.4 Pfizer Revenue in Persistent Facial Erythema Treatment Business (2018-2023)

11.6.5 Pfizer Recent Development

11.7 Regeneron Pharmaceuticals

11.7.1 Regeneron Pharmaceuticals Company Detail

11.7.2 Regeneron Pharmaceuticals Business Overview

11.7.3 Regeneron Pharmaceuticals Persistent Facial Erythema Treatment Introduction

11.7.4 Regeneron Pharmaceuticals Revenue in Persistent Facial Erythema Treatment Business (2018-2023)

11.7.5 Regeneron Pharmaceuticals Recent Development

11.8 Sanofi

11.8.1 Sanofi Company Detail

11.8.2 Sanofi Business Overview

11.8.3 Sanofi Persistent Facial Erythema Treatment Introduction

11.8.4 Sanofi Revenue in Persistent Facial Erythema Treatment Business (2018-2023)

11.8.5 Sanofi Recent Development

11.9 Bausch Health

11.9.1 Bausch Health Company Detail

11.9.2 Bausch Health Business Overview

11.9.3 Bausch Health Persistent Facial Erythema Treatment Introduction

11.9.4 Bausch Health Revenue in Persistent Facial Erythema Treatment Business (2018-2023)

11.9.5 Bausch Health Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Persistent Facial Erythema Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Emollients

    Table 3. Key Players of Antihistamines

    Table 4. Key Players of Antifungal

    Table 5. Key Players of Antibiotics

    Table 6. Key Players of Corticosteroids

    Table 7. Key Players of Calcineurin Inhibitors

    Table 8. Global Persistent Facial Erythema Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 9. Global Persistent Facial Erythema Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 10. Global Persistent Facial Erythema Treatment Market Size by Region (2018-2023) & (US$ Million)

    Table 11. Global Persistent Facial Erythema Treatment Market Share by Region (2018-2023)

    Table 12. Global Persistent Facial Erythema Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 13. Global Persistent Facial Erythema Treatment Market Share by Region (2024-2029)

    Table 14. Persistent Facial Erythema Treatment Market Trends

    Table 15. Persistent Facial Erythema Treatment Market Drivers

    Table 16. Persistent Facial Erythema Treatment Market Challenges

    Table 17. Persistent Facial Erythema Treatment Market Restraints

    Table 18. Global Persistent Facial Erythema Treatment Revenue by Players (2018-2023) & (US$ Million)

    Table 19. Global Persistent Facial Erythema Treatment Market Share by Players (2018-2023)

    Table 20. Global Top Persistent Facial Erythema Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Persistent Facial Erythema Treatment as of 2022)

    Table 21. Ranking of Global Top Persistent Facial Erythema Treatment Companies by Revenue (US$ Million) in 2022

    Table 22. Global 5 Largest Players Market Share by Persistent Facial Erythema Treatment Revenue (CR5 and HHI) & (2018-2023)

    Table 23. Key Players Headquarters and Area Served

    Table 24. Key Players Persistent Facial Erythema Treatment Product Solution and Service

    Table 25. Date of Enter into Persistent Facial Erythema Treatment Market

    Table 26. Mergers & Acquisitions, Expansion Plans

    Table 27. Global Persistent Facial Erythema Treatment Market Size by Type (2018-2023) & (US$ Million)

    Table 28. Global Persistent Facial Erythema Treatment Revenue Market Share by Type (2018-2023)

    Table 29. Global Persistent Facial Erythema Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 30. Global Persistent Facial Erythema Treatment Revenue Market Share by Type (2024-2029)

    Table 31. Global Persistent Facial Erythema Treatment Market Size by Application (2018-2023) & (US$ Million)

    Table 32. Global Persistent Facial Erythema Treatment Revenue Market Share by Application (2018-2023)

    Table 33. Global Persistent Facial Erythema Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 34. Global Persistent Facial Erythema Treatment Revenue Market Share by Application (2024-2029)

    Table 35. North America Persistent Facial Erythema Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 36. North America Persistent Facial Erythema Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 37. North America Persistent Facial Erythema Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 38. Europe Persistent Facial Erythema Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 39. Europe Persistent Facial Erythema Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 40. Europe Persistent Facial Erythema Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 41. Asia-Pacific Persistent Facial Erythema Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 42. Asia-Pacific Persistent Facial Erythema Treatment Market Size by Region (2018-2023) & (US$ Million)

    Table 43. Asia-Pacific Persistent Facial Erythema Treatment Market Size by Region (2024-2029) & (US$ Million)

    Table 44. Latin America Persistent Facial Erythema Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 45. Latin America Persistent Facial Erythema Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 46. Latin America Persistent Facial Erythema Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 47. Middle East & Africa Persistent Facial Erythema Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 48. Middle East & Africa Persistent Facial Erythema Treatment Market Size by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Persistent Facial Erythema Treatment Market Size by Country (2024-2029) & (US$ Million)

    Table 50. Anacor Pharmaceuticals Company Detail

    Table 51. Anacor Pharmaceuticals Business Overview

    Table 52. Anacor Pharmaceuticals Persistent Facial Erythema Treatment Product

    Table 53. Anacor Pharmaceuticals Revenue in Persistent Facial Erythema Treatment Business (2018-2023) & (US$ Million)

    Table 54. Anacor Pharmaceuticals Recent Development

    Table 55. Astellas Pharma Company Detail

    Table 56. Astellas Pharma Business Overview

    Table 57. Astellas Pharma Persistent Facial Erythema Treatment Product

    Table 58. Astellas Pharma Revenue in Persistent Facial Erythema Treatment Business (2018-2023) & (US$ Million)

    Table 59. Astellas Pharma Recent Development

    Table 60. Galderma Company Detail

    Table 61. Galderma Business Overview

    Table 62. Galderma Persistent Facial Erythema Treatment Product

    Table 63. Galderma Revenue in Persistent Facial Erythema Treatment Business (2018-2023) & (US$ Million)

    Table 64. Galderma Recent Development

    Table 65. Meda Pharmaceuticals Company Detail

    Table 66. Meda Pharmaceuticals Business Overview

    Table 67. Meda Pharmaceuticals Persistent Facial Erythema Treatment Product

    Table 68. Meda Pharmaceuticals Revenue in Persistent Facial Erythema Treatment Business (2018-2023) & (US$ Million)

    Table 69. Meda Pharmaceuticals Recent Development

    Table 70. Novartis Company Detail

    Table 71. Novartis Business Overview

    Table 72. Novartis Persistent Facial Erythema Treatment Product

    Table 73. Novartis Revenue in Persistent Facial Erythema Treatment Business (2018-2023) & (US$ Million)

    Table 74. Novartis Recent Development

    Table 75. Pfizer Company Detail

    Table 76. Pfizer Business Overview

    Table 77. Pfizer Persistent Facial Erythema Treatment Product

    Table 78. Pfizer Revenue in Persistent Facial Erythema Treatment Business (2018-2023) & (US$ Million)

    Table 79. Pfizer Recent Development

    Table 80. Regeneron Pharmaceuticals Company Detail

    Table 81. Regeneron Pharmaceuticals Business Overview

    Table 82. Regeneron Pharmaceuticals Persistent Facial Erythema Treatment Product

    Table 83. Regeneron Pharmaceuticals Revenue in Persistent Facial Erythema Treatment Business (2018-2023) & (US$ Million)

    Table 84. Regeneron Pharmaceuticals Recent Development

    Table 85. Sanofi Company Detail

    Table 86. Sanofi Business Overview

    Table 87. Sanofi Persistent Facial Erythema Treatment Product

    Table 88. Sanofi Revenue in Persistent Facial Erythema Treatment Business (2018-2023) & (US$ Million)

    Table 89. Sanofi Recent Development

    Table 90. Bausch Health Company Detail

    Table 91. Bausch Health Business Overview

    Table 92. Bausch Health Persistent Facial Erythema Treatment Product

    Table 93. Bausch Health Revenue in Persistent Facial Erythema Treatment Business (2018-2023) & (US$ Million)

    Table 94. Bausch Health Recent Development

    Table 95. Research Programs/Design for This Report

    Table 96. Key Data Information from Secondary Sources

    Table 97. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Persistent Facial Erythema Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Persistent Facial Erythema Treatment Market Share by Type: 2022 VS 2029

    Figure 3. Emollients Features

    Figure 4. Antihistamines Features

    Figure 5. Antifungal Features

    Figure 6. Antibiotics Features

    Figure 7. Corticosteroids Features

    Figure 8. Calcineurin Inhibitors Features

    Figure 9. Global Persistent Facial Erythema Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 10. Global Persistent Facial Erythema Treatment Market Share by Application: 2022 VS 2029

    Figure 11. Hospitals Case Studies

    Figure 12. Ambulatory Surgical Centers Case Studies

    Figure 13. Clinics Case Studies

    Figure 14. Others Case Studies

    Figure 15. Persistent Facial Erythema Treatment Report Years Considered

    Figure 16. Global Persistent Facial Erythema Treatment Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 17. Global Persistent Facial Erythema Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 18. Global Persistent Facial Erythema Treatment Market Share by Region: 2022 VS 2029

    Figure 19. Global Persistent Facial Erythema Treatment Market Share by Players in 2022

    Figure 20. Global Top Persistent Facial Erythema Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Persistent Facial Erythema Treatment as of 2022)

    Figure 21. The Top 10 and 5 Players Market Share by Persistent Facial Erythema Treatment Revenue in 2022

    Figure 22. North America Persistent Facial Erythema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. North America Persistent Facial Erythema Treatment Market Share by Country (2018-2029)

    Figure 24. United States Persistent Facial Erythema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Canada Persistent Facial Erythema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Europe Persistent Facial Erythema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Europe Persistent Facial Erythema Treatment Market Share by Country (2018-2029)

    Figure 28. Germany Persistent Facial Erythema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. France Persistent Facial Erythema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. U.K. Persistent Facial Erythema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Italy Persistent Facial Erythema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Russia Persistent Facial Erythema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Nordic Countries Persistent Facial Erythema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Asia-Pacific Persistent Facial Erythema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Asia-Pacific Persistent Facial Erythema Treatment Market Share by Region (2018-2029)

    Figure 36. China Persistent Facial Erythema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Japan Persistent Facial Erythema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. South Korea Persistent Facial Erythema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Southeast Asia Persistent Facial Erythema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. India Persistent Facial Erythema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Australia Persistent Facial Erythema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Latin America Persistent Facial Erythema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Latin America Persistent Facial Erythema Treatment Market Share by Country (2018-2029)

    Figure 44. Mexico Persistent Facial Erythema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Brazil Persistent Facial Erythema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Middle East & Africa Persistent Facial Erythema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Middle East & Africa Persistent Facial Erythema Treatment Market Share by Country (2018-2029)

    Figure 48. Turkey Persistent Facial Erythema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 49. Saudi Arabia Persistent Facial Erythema Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 50. Anacor Pharmaceuticals Revenue Growth Rate in Persistent Facial Erythema Treatment Business (2018-2023)

    Figure 51. Astellas Pharma Revenue Growth Rate in Persistent Facial Erythema Treatment Business (2018-2023)

    Figure 52. Galderma Revenue Growth Rate in Persistent Facial Erythema Treatment Business (2018-2023)

    Figure 53. Meda Pharmaceuticals Revenue Growth Rate in Persistent Facial Erythema Treatment Business (2018-2023)

    Figure 54. Novartis Revenue Growth Rate in Persistent Facial Erythema Treatment Business (2018-2023)

    Figure 55. Pfizer Revenue Growth Rate in Persistent Facial Erythema Treatment Business (2018-2023)

    Figure 56. Regeneron Pharmaceuticals Revenue Growth Rate in Persistent Facial Erythema Treatment Business (2018-2023)

    Figure 57. Sanofi Revenue Growth Rate in Persistent Facial Erythema Treatment Business (2018-2023)

    Figure 58. Bausch Health Revenue Growth Rate in Persistent Facial Erythema Treatment Business (2018-2023)

    Figure 59. Bottom-up and Top-down Approaches for This Report

    Figure 60. Data Triangulation

    Figure 61. Key Executives Interviewed